WILLIAM J. RIEFLIN

Profile

First Name

: WILLIAM

Middle Name

: J.

Last Name

: RIEFLIN

Related Companies

Titles

Company Name

Related People

DIRECTOR

VINCENT J. ANGOTTI, RONALD W. BARRETT, GREGORY T. BATES, PAUL L. BERNS, GIANNA M. BOSKO, DENNIS M. FENTON, JOHN G. FREUND, CATHERINE J. FRIEDMAN, WILLIAM G. HARRIS, JERYL L. HILLEMAN, ERNEST MARIO, DAVID R. SAVELLO, WENDELL WIERENGA

EXECUTIVE OFFICER, DIRECTOR

NGM BIOPHARMACEUTICALS INC

LUIS BAYOL, JIN-LONG CHEN, DAVID GOEDDEL, DAVID V. GOEDDEL, HELEN KIM, MARC LESCHLY, MARK LESCHLY, ARTHUR LEVINSON, ARTHUR D. LEVINSON, WILLIAM RIEFLIN, DAVID SCHNELL, PETER SVENNILSON, MCHENRY T. TICHENOR, JR.

DIRECTOR

DIRK BROCKSTEDT, MICHAEL GIORDANO, MICHAEL F. GIORDANO, DAVID GOEDDEL, DAVID V. GOEDDEL, MARY ANN V. GRAY, ERIC HALL, REKHA HEMRAJANI, WILLIAM HO, PAUL KASSNER, LINDA KOZICK, TIM LIN, LORI LYONS-WILLIAMS, WENDYE ROBBINS, BETH SEIDENBERG, BRIAN WONG, DAVID WUSTROW, RODNEY YOUNG

DIRECTOR

RAPT THERAPEUTICS, INC.

DIRK BROCKSTEDT, MICHAEL GIORDANO, MICHAEL F. GIORDANO, DAVID GOEDDEL, DAVID V. GOEDDEL, MARY ANN V. GRAY, ERIC HALL, REKHA HEMRAJANI, WILLIAM HO, PAUL KASSNER, LINDA KOZICK, TIM LIN, LORI LYONS-WILLIAMS, WENDYE ROBBINS, BETH SEIDENBERG, BRIAN WONG, DAVID WUSTROW, RODNEY YOUNG

DIRECTOR

NGM BIO HOLDINGS, INC.

DIANA PENG BOCKUS, KARA CALHOUN, DAVID GOEDDEL, SHELLY D. GUYER, CAROLE HO, DANIEL KAPLAN, TIM KUTZKEY, HSIAO D. LIEU, ROGER M. PERLMUTTER, VALERIE PIERCE, PETER SVENNILSON, JEAN-FREDERIC VIRET, DAVID J. WOODHOUSE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2024-12-27

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-07-05

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2022-05-27

D/A

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2018-12-18

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-12-18

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-12-15

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-04-21

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-03-20

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2014-10-09

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-04-09

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

$25,000,001 - $100,000,000

Equity

2012-11-08